Showing 1 - 10 of 97
Objective: To determine the sensitivity of employees’ health insurance decisions—including the decision to not choose health maintenance organization or fee-for-service coverage—during periods of rapidly escalating healthcare costs. Study Design: A retrospective cohort study of employee...
Persistent link: https://www.econbiz.de/10005260197
Ein analytisches Modell mit acht Parametern zur Beschreibung idealisierter Ponzi-Systeme mit asymmetrisch und progressiv wachsenden Kapitalzu- und -abflüssen wird präsentiert. Investoren bleiben optional zeitlich begrenzt oder dauerhaft investiert. Diverse Systemvarianten inklusive deren...
Persistent link: https://www.econbiz.de/10011110795
We study size and growth distributions of products and business firms in the context of a given industry. Firm size growth is analyzed in terms of two basic mechanisms, i.e. the increase of the number of new elementary business units and their size growth. We find a power-law relationship...
Persistent link: https://www.econbiz.de/10005020505
Since Comanor and Scherer (1969), researchers have been using patents as a proxy for new product development. In this paper, we reevaluate this relationship by using novel new data. We demonstrate that the relationship between patenting and new FDA-approved product introductions has diminished...
Persistent link: https://www.econbiz.de/10005790197
In 1970 the USA spent 7% of its GNP on healthcare, in 200716%. Whereas the OECD average per capita expenditure on healthcare in 2007 was $2,964, the USA spent $7,290. Yet in that same period, the health of America’s citizens relative to those of other developed countries declined dramatically,...
Persistent link: https://www.econbiz.de/10008544705
The study tests the FDI spillover hypothesis in the Indian Pharmaceutical industry using an unbalanced panel data for a sample of firms over the period 1989-90 to 2000-01. The study estimates firm-specific productive efficiency growth for domestic firms from frontier production function and...
Persistent link: https://www.econbiz.de/10005059093
An explosion of knowledge and a growing array of tools and technologies have transformed modern drug R&D, while its cost has risen by a sizable amount. At the same time, the unchecked increase in health care and prescription drug spending has spawned cost containment policies that are...
Persistent link: https://www.econbiz.de/10005109573
Complex systems can be characterized by classes of equivalency of their elements defined according to system specific rules. We propose a generalized preferential attachment model to describe the class size distribution. The model postulates preferential growth of the existing classes and the...
Persistent link: https://www.econbiz.de/10005031401
We study the betweenness centrality of fractal and non-fractal scale-free network models as well as real networks. We show that the correlation between degree and betweenness centrality C of nodes is much weaker in fractal network models compared to non-fractal models. We also show that nodes of...
Persistent link: https://www.econbiz.de/10005031411
The report examines the competitive position of the European pharmaceutical companies and industries, and compares them with the pharmaceutical companies and industries in other parts of the world, particularly the US. Over the last two decades, the industry has experienced some important...
Persistent link: https://www.econbiz.de/10005034968